STOCK TITAN
  1. Home
  2. Sec-filings
  3. CSCI
  4. [EFFECT] COSCIENS Biopharma Inc. SEC Filing

[EFFECT] COSCIENS Biopharma Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 18, 2026
Accession Number: 0001493152-26-010110
Submission Type: POS AM
CIK: 0001113423
Company Name: COSCIENS Biopharma Inc.
File Number: 333-239019

Source: View Original Filing on SEC EDGAR

Cosciens Biopharma

NASDAQ:CSCI

View CSCI Stock Overview →

CSCI Rankings

#6473 Ranked by Market Cap
N/A Ranked by Dividends

CSCI Latest News

Dec 1, 2025
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore
Nov 14, 2025
COSCIENS Biopharma Inc. Announces Leadership Change
Nov 11, 2025
COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update
Aug 14, 2025
COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update
Jun 30, 2025
COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

CSCI Latest SEC Filings

Mar 19, 2026
[EFFECT] COSCIENS Biopharma Inc. SEC Filing
Mar 13, 2026
[POS AM] COSCIENS Biopharma Inc. SEC Filing
Mar 13, 2026
[POS AM] COSCIENS Biopharma Inc. SEC Filing
Mar 13, 2026
[POS AM] COSCIENS Biopharma Inc. SEC Filing
Mar 13, 2026
[POS AM] COSCIENS Biopharma Inc. SEC Filing

CSCI Stock Data

8.64M
3.13M
Biotechnology
Healthcare
Link
Canada
Toronto